skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

43 studies were found about isoniazid

Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons

Condition: Tuberculosis; Latent Tuberculosis Infection; HIV Infections

NCT ID: NCT00463086

Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00164281

Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV

Condition: HIV Infection; Tuberculosis; Pneumocystis Jiroveci Pneumonia

NCT ID: NCT00080119

Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)

Condition: Human Immunodeficiency Virus (HIV); Tuberculosis (TB); Latent Tuberculosis Infection (LTI)

NCT ID: NCT01875952

TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023348

Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00495651

Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01494038

Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection

Condition: Tuberculosis; HIV Infections

NCT ID: NCT01404312

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000636

Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000638

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000959

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000950

A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00402610

ENhance Initiation and Retention in Isoniazid Preventive Therapy (IPT) Care for HIV Study (ENRICH Study)

Condition: HIV; Tuberculosis

NCT ID: NCT01926379

A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000778

Preventive Therapy for Tuberculosis in HIV Infected Persons

Condition: Human Immunodeficiency Virus; Tuberculosis

NCT ID: NCT00351702

Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00018083

Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis

Condition: Tuberculosis; Human Immunodeficiency Virus Infections

NCT ID: NCT00376012

The Treatment of Tuberculosis in HIV-Infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00001033

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000796

Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3

Condition: HIV-1 Infection

NCT ID: NCT02057796

TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00107887

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023413

Tuberculosis Prevention for HIV Infected Adults

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00057122

Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy

Condition: Human Immunodeficiency Virus

NCT ID: NCT01825031

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

Condition: HIV Infections

NCT ID: NCT00402454

TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023400

REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment

Condition: HIV Infection

NCT ID: NCT01380080

Do Clinical Decision-support Reminders for Medical Providers Improve the Do Clinical Decision-support Reminders for Medical Providers Improve the Prevalence of IPT Initiation Among HIV Positive Adults in Western Kenya?

Condition: Tuberculosis

NCT ID: NCT01934309

Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana

Condition: Tuberculosis; HIV

NCT ID: NCT01687504

Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children

Condition: Tuberculosis

NCT ID: NCT00330304

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00004736

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV

Condition: HIV Infection; Tuberculosis

NCT ID: NCT01601626

Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment

Condition: HIV; AIDS; Tuberculosis

NCT ID: NCT00737724

Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)

Condition: Tuberculosis; Aids; Hiv Infections

NCT ID: NCT00495326

Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis

Condition: TB Multi-drug Resistant

NCT ID: NCT00396084

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)

Condition: Tuberculosis; HIV

NCT ID: NCT01637558

Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes

Condition: AIDS With Tuberculosis

NCT ID: NCT01782950

TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023361

Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination

Condition: Mycobacterium Tuberculosis

NCT ID: NCT01119521

TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine

Condition: Tuberculosis

NCT ID: NCT00023387

Tuberculosis Treatment Shortening Trial

Condition: Tuberculosis

NCT ID: NCT00130247

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Condition: HIV Infections

NCT ID: NCT00042289